Liz Dallimore – CEO & Managing Director – Argenica Therapeutics is developing novel neuroprotective therapeutics to reduce brain damage after stroke.
Views: 675
Liz Dallimore – CEO & Managing Director – Argenica Therapeutics is developing novel neuroprotective therapeutics to reduce brain damage after stroke.